4538.T
Fuso Pharmaceutical Industries,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 2,272.00
−0.61%Year over year
Reported trailing growth
- Revenue
- +2.9%
- EBITDA
- —
- EBIT
- -36.1%
- EPS
- +161.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -1.3%
- EBITDA
- —
- EPS
- +14.3%
Three-year CAGR
- Revenue
- +6.9%
- EBITDA
- +3.9%
- EBIT
- +6.2%
- Net income
- +7.8%
- EPS
- +8.8%
- Free cash flow
- -38.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026